241 |
Effects of a New Conjugate Drug in a Rat Model of Postmenopausal OsteoporosisLiu, Careesa Chang 04 December 2013 (has links)
Postmenopausal osteoporosis is a disease characterized by bone loss and increased risk of fracture, and represents a significant burden on the Canadian health care system. Current treatments lack the ability to simultaneously address the therapeutic needs for promoting bone formation and inhibiting resorption. Our approach employs a novel conjugate drug in which an anabolic agent (EP4 receptor agonist) is reversibly joined with an anti-resorptive agent (alendronate) through a linker. This allows the bone-targeting ability of alendronate to deliver the EP4 agonist to bone sites, thereby mitigating the side effects associated with systemic administration of the EP4 agonist. This study investigated the in vivo efficacy of this drug in a curative experiment to treat postmenopausal osteoporosis using an ovariectomized rat model. Results showed that conjugate treatment dose-dependently stimulated bone formation and restored ovariectomy-induced bone loss, and conjugation between alendronate and the EP4 agonist was crucial to the drug’s anabolic effect.
|
242 |
Effects of a New Conjugate Drug in a Rat Model of Postmenopausal OsteoporosisLiu, Careesa Chang 04 December 2013 (has links)
Postmenopausal osteoporosis is a disease characterized by bone loss and increased risk of fracture, and represents a significant burden on the Canadian health care system. Current treatments lack the ability to simultaneously address the therapeutic needs for promoting bone formation and inhibiting resorption. Our approach employs a novel conjugate drug in which an anabolic agent (EP4 receptor agonist) is reversibly joined with an anti-resorptive agent (alendronate) through a linker. This allows the bone-targeting ability of alendronate to deliver the EP4 agonist to bone sites, thereby mitigating the side effects associated with systemic administration of the EP4 agonist. This study investigated the in vivo efficacy of this drug in a curative experiment to treat postmenopausal osteoporosis using an ovariectomized rat model. Results showed that conjugate treatment dose-dependently stimulated bone formation and restored ovariectomy-induced bone loss, and conjugation between alendronate and the EP4 agonist was crucial to the drug’s anabolic effect.
|
243 |
Mechanisms of over-active endothelium-derived contracting factor signaling causing common carotid artery endothelial vasomotor dysfunction in hypertension and agingDenniss, Steven January 2011 (has links)
Background and Purpose:
The endothelium is a single-cell layer positioned at the blood-vascular wall interface, where in response to blood-borne signals and hemodynamic forces, endothelial cells act as central regulators of vascular homeostatic processes including vascular tone, growth and remodeling, inflammation and adhesion, and blood fluidity and coagulation. Agonist- or flow-stimulated endothelium-dependent vasorelaxation becomes impaired in states of cardiovascular disease (CVD) risk and has been identified as a possible biomarker of overall endothelial dysfunction leading to vascular dysregulation and disease pathogenesis. Accordingly, it is important to elucidate the mechanisms accounting for this endothelial vasomotor dysfunction. Upon stimulation, endothelial cells can synthesize and release a variety of endothelium-derived relaxing factors (EDRFs), the most prominent of which is nitric oxide (NO) derived from NO synthase (NOS). In addition, under certain CVD risk conditions including hypertension and aging, stimulated endothelial cells can become a prominent source of endothelium-derived contracting factors (EDCFs) produced in a cyclooxygenase (COX)-dependent manner. Consequently, endothelial dysfunction may be caused by under-active EDRF signaling and/or competitive over-active EDCF signaling. Much attention has been given to elucidating the mechanisms of under-active EDRF signaling and its role in causing endothelial dysfunction, wherein excess reactive oxygen species (ROS) accumulation and oxidative stress under CVD risk conditions have been recognized as major factors in reducing NO bioavailability thus causing under-active EDRF signaling and endothelial dysfunction. Less attention however, has been given to elucidating the mechanisms of over-active COX-mediated EDCF signaling and its role in causing endothelial dysfunction. Moreover, while COX-mediated EDCF signaling activity has been investigated in some segments of the vasculature, most notably the aorta, it has not been well-investigated in the common carotid artery (CCA), a highly accessible cerebral blood flow conduit particularly advantageous in exploring the roles of the endothelium in vascular pathogenesis. It was the global purpose of this thesis to gain a better understanding of the cellular-molecular mechanisms accounting for endothelial dysfunction in the CCA of animal models known to exhibit COX-mediated EDCF signaling activity, in particular essential (spontaneous) hypertension and aging.
Experimental Objective and Approach:
This thesis comprises three studies. Study I and Study II investigated the CCA of young-adult (16-24wk old) normotensive Wistar Kyoto (WKY) and Spontaneously Hypertensive (SHR) rats. Study III investigated the CCA of Adult (25-36wks old) and Aging (60-75wks old) Sprague Dawley (SD) rats treated in vivo (or not; CON) with L-buthionine sulfoximine (BSO) to chronically deplete the cellular anti-oxidant glutathione (GSH) and increase ROS accumulation and oxidative stress. The global objective and approach across these studies was to systematically examine the relative contributions of NOS and COX signaling pathways in mediating the acetylcholine (ACh)-stimulated endothelium-dependent relaxation (EDRF) and contractile (EDCF) activities of isometrically-mounted CCA in tissue baths in vitro, with a particular focus on elucidating the mechanisms of COX-mediated EDCF signaling activity. An added objective was to examine the in vivo hemodynamic characteristics of the CCA in each animal model investigated, serving both to identify the pressure-flow environment that the CCA is exposed to in vivo and to provide assessment of potential hypertension, aging, and oxidative stress effects on large artery hemodynamics.
Key Findings:
Study I hemodynamic analysis confirmed a hypertensive state in young adult SHR while also exposing a reduction in mean CCA blood flow in SHR compared to WKY accompanied by a multi-faceted pressure-flow interaction across the cardiac cycle relating to flow and pressure augmentation. Study III hemodynamic analysis found that neither aging nor chronic BSO-induced GSH depletion affected CCA blood pressure or blood flow parameters in SD rats.
Study I and II demonstrated that a COX-mediated EDCF response impaired ACh-stimulated endothelium-dependent vasorelaxation in pre-contracted CCA from young adult SHR, while EDRF signaling activity, predominantly mediated by NO, remained well-preserved compared to WKY. Examining ACh-stimulated contractile function specifically from a quiescent (non pre-contracted) state revealed that EDCF activity did exist in WKY CCA but could be completely suppressed by NO-mediated EDRF signaling activity, whereas the similarly robust NO-meditated EDRF signaling activity in SHR CCA could not fully suppress its >2-fold augmented EDCF activity vs. WKY CCA. Further pharmaco-dissection of ACh-stimulated contractile function in the SHR-WKY CCA model revealed that the EDCF signaling activity was completely dependent on the COX-1 (but not COX-2) isoform of COX and was almost exclusively mediated by the thromboxane-prostanoid (TP) sub-type of the prostaglandin (PG) G-protein coupled receptor family and by Rho-associated kinase (ROCK), a down-stream effector of the molecular switch RhoA. Furthermore, it was found that while exogenous ROS-stimulated CCA contractile function was similarly >2-fold augmented in SHR vs. WKY and dependent on COX-1 and TP receptor and ROCK effectors, ACh-stimulated CCA EDCF signaling activity was only minimally affected by in-bath ROS manipulating compounds. Additional biochemical and molecular analysis revealed that ACh stimulation was associated with PG over-production from an over-expressed COX-1 in SHR CCA, and with CCA plasma membrane localization and activation of RhoA.
Study III demonstrated that a COX-mediated EDCF response impaired ACh-stimulated endothelium-dependent vasorelaxation in pre-contracted CCA from Aging SD rats, while EDRF signaling activity, predominantly mediated by NO, remained well-preserved compared to Adult SD rats. Specific examination of ACh-stimulated contractile function revealed that EDCF activity did exist in Adult CCA but could be completely suppressed by NO-mediated EDRF signaling activity, whereas the similarly robust NO-meditated EDRF signaling activity in Aging CCA could not fully suppress its >3-fold augmented EDCF activity vs. Adult CCA. Further pharmaco-dissection of ACh-stimulated contractile function in the Adult-Aging SD rat CCA model revealed that EDCF signaling activity was completely dependent on COX-1, but while exogenous ROS was able to elicit a COX-dependent CCA contractile response, in-bath ROS manipulating compounds were found to be without effect on ACh-stimulated CCA EDCF signaling activity. Furthermore, biochemical analysis revealed that aging was not associated with a change in tissue (liver and vascular) GSH content or ROS accumulation. Chronic in vivo BSO treatment was effective in depleting tissue GSH content and increasing ROS accumulation, to a similar extent, in both Adult and Aging SD rats. However, regardless of age, neither ACh-stimulated NO-mediated EDRF signaling activity nor COX-mediated EDCF signaling activity were affected by these BSO-induced perturbations.
Conclusions and Perspective:
In the CCA of animals at the early pathological stages of either essential hypertension (young adult SHR) or normotensive aging (Aging SD rats), endothelial vasomotor dysfunction can be caused solely by over-active EDCF signaling, apparently disconnected from changes in NO bioavailability or oxidative stress. While NO and ROS may act, respectively, as negative and positive modulators of the established COX-PG-TP receptor-RhoA-ROCK cell-signaling axis mediating endothelium-dependent contractile activity, these factors do not appear to be essential to the mechanism(s) underlying the development of over-active EDCF signaling. Further elucidation of the cellular-molecular causes of over-active EDCF signaling, and its patho-biological consequences, in the SHR-WKY and Adult-Aging SD rat CCA models of EDCF activity established and hemodynamically characterized in this thesis, may help to identify new or more effective targets to be used in prevention or treatment strategies to combat the pathogenesis of CVD.
|
244 |
SMAD3 in embryonic patterning, mesoderm induction, and colorectal cancer in the mouseWieduwilt, Matthew J. January 2003 (has links) (PDF)
Thesis (Ph. D.) -- University of Texas Southwestern Medical Center at Dallas, 2003. / Vita. Bibliography: 180-208.
|
245 |
Aspectos imunopatogênicos da leishmaniose cutânea difusa: fatores da leishmania e do hospedeiroCosta, Jaqueline França January 2013 (has links)
Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2013-11-06T14:31:55Z
No. of bitstreams: 1
Jaqueline Franca Costa Aspectos imunopatogênicos da leishmaniose cutanêa...pdf: 1509776 bytes, checksum: 2d3824cc711f84d908e61378ac3d4a8c (MD5) / Made available in DSpace on 2013-11-06T14:31:55Z (GMT). No. of bitstreams: 1
Jaqueline Franca Costa Aspectos imunopatogênicos da leishmaniose cutanêa...pdf: 1509776 bytes, checksum: 2d3824cc711f84d908e61378ac3d4a8c (MD5)
Previous issue date: 2013 / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / A progressão crônica da LCD é atribuída à falta da imunidade mediada por células específica para antígeno de Leishmania e predominância de uma resposta do tipo Th2. Neste sentido, tanto fatores do parasita quanto do hospedeiro podem atuar na desativação da resposta imune favorecendo a replicação da Leishmania. Inicialmente avaliamos o papel da exposição de fosfatidilserina na infecção de macrófagos murinos com Leishmania amazonensis isolados de pacientes com LCD. Para isso, macrófagos peritoneais de camundongos F1(BALB/c x C57BL/6) foram infectados com os diferentes isolados obtidos de pacientes com LCD e LCL. Os isolados obtidos de pacientes com LCD apresentaram maior expressão de PS do que os isolados de pacientes com LCL após 24 horas de infecção. Em seguida, avaliamos a infectividade dos diferentes isolados. As amastigotas de pacientes com LCD apresentaram maior porcentagem de macrófagos infectados e índice de infecção, quando comparados com amastigotas de pacientes com LCL. Quanto ao mecanismo, o grupo infectado com os isolados de pacientes com LCD apresentou um aumento na relação TGF-β/TNF-α e IL-10/TNF-α em relação ao grupo LCL. A análise de correlação revelou que a porcentagem de macrófagos infectados, o índice de infecção, os índices de TGF-β/TNF-α e IL-10/TNF-α, bem como o tamanho dos vacúolos estão diretamente associados a maior exposição de PS. Além disso, o número de lesões e o tempo de doença dos pacientes com LCD também estão associados á exposição de PS. O reconhecimento de PS tem como consequência a produção de TGF, IL-10, IL-4 e PGE2, que ativam a via da enzima arginase e consequentemente a produção de poliaminas. Por isso buscamos investigar a participação de tais mediadores em pacientes com LCD. Os níveis da arginase I, ODC e TGF-β no plasma de pacientes com LCD estava elevados quando comparado com os pacientes com LCL ou o controle saudável da área endêmica. Por outro lado, os níveis de TNF-α, IL-12, MCP-1 e CXCL-10 estavam reduzidos no plasma de pacientes com LCD comparado aos pacientes com LCL. Os níveis de arginase apresentaram correlação positiva com ODC, TGF-β e PGE e correlação negativa com TNF-α, IL-12, MCP-1 e CXCL-10. A produção da arginase e ODC também foi avaliada nas lesões dos pacientes através de imunohistoquímica. As lesões dos pacientes com LCD apresentaram uma marcação mais intensa e difusa do que as de LCL. Além disso, a expressão da cicloxigenase 2 também estava aumentada nas lesões de LCD. A expressão do mRNA das enzimas fosfolipase A2, COX-2, prostaglandina sintase, espermina e espermidina sintase apresentaram uma relação positiva com a enzima arginase, indicando que esta interfere diretamente no metabolismo dos mediadores lipídicos e na via de síntese das poliaminas. A inibição das enzimas arginase e ODC com nor-NOHA e DFMO, respectivamente, reduziu a carga parasitária de macrófagos humanos infectados com L. amazonensis após 72 h de infecção. Além disso, os inibidores reduziram a produção de TGF e PGE2 no sobrenadante das culturas. Em conjunto, nossos dados sugerem que a liberação local e sistêmica de prostaglandinas e poliaminas associadas à via da arginase em pacientes com LCD deve estar associada com a inabilidade em montar uma resposta imune eficiente contra a infecção por Leishmania proporcionando um ambiente favorável para a replicação do parasita e disseminação da doença. Nossos resultados mostram também que este ambiente imunossuprimido pode ser induzido pela exposição de PS na superfície de L. amazonensis deflagrando uma resposta anti-inflamatória nos pacientes com LCD. / The chronic progression of DCL is attributed to the lack of specific cell-mediated immunity to Leishmania antigen and predominance of a Th2-type response. In this sense, both factors of the parasite and the host can act in the deactivation of immune response, favoring parasite replication. Initially we evaluate the role of phosphatidylserine exposure in murine macrophages infected with L. amazonensis isolated from patients with DCL. First, peritoneal macrophages of mice F1 (BALB/c x C57BL/6) were infected with different isolates from patients with DCL and LCL. The DCL isolates showed higher PS expression than the LCL isolates after 24 hours of infection.. The DCL-amastigotes patients showed a higher percentage of infected macrophages and the infectivity index when compared with patients with LCL- amastigotes. Regarding the mechanism, the group infected with isolates from patients with LCD showed an increase in TGF/TNF and IL-10/TNF when compared with LCL group. Correlation analysis revealed that the percentage of infected macrophages, the infectivity index, the rate of TGF/TNF and IL-10/TNF as well as the size of the vacuoles are directly associated with higher PS exposure. Moreover, the number of lesions and disease duration of DCL patients are also associated with PS exposure. Recognition of PS results in the production of TGF, IL-10, IL-4 and PGE2, molecules with anti-inflammatory role that activate the enzyme arginase and consequently the polyamines production. Therefore, we investigated the involvement of these mediators in patients with DCL. The plasma of DCL patients showed high levels of arginase, ODC and TGF compared to the LCL patients or healthy control from endemic area. On the other hand, the levels of TNF, IL-12, MCP-1 and CXCL-10 were reduced in the DCL patients plasma compared to patients with LCL. Arginase levels were positively correlated with ODC, TGF and PGE and negatively correlated with TNF, IL-12, MCP-1 and CXCL-10. The production of arginase and ODC was also evaluated in the lesions of patients by immunohistochemistry. The DCL lesions showed a more intense and diffuse staining than LCL lesions. Furthermore, the expression of cyclooxygenase-2 was also increased in lesions of DCL. The mRNA expression of the enzymes phospholipase A2, COX-2, prostaglandin synthase, spermine synthase and spermidine synthase showed a positive relationship with the arginase enzyme, indicating that it directly interferes with the metabolism of lipid mediators and in synthesis of polyamines. The inhibition of the enzyme arginase and ODC with nor-NOHA and DFMO, respectively, reduced the parasite load of L. amazonensis human infected macrophages 72 h after infection. Moreover, NOHA and DFMO reduced TGF and PGE2 production in the supernatant of cultures. Together, local and systemic release of prostaglandins, arginase and polyamines pathways in DCL should be associated with the inability of these patients to mount effective immune response against infection by Leishmania providing a favorable environment for replication and spread of the parasite disease. Our results also show that this immunosuppressed environment can be induced by PS exposure on the L. amazonensis surface triggering anti-inflammatory response in DCL patients.
|
246 |
Produção de colostro e desempenho da leitegada em fêmeas suínas multíparas submetidas à indução em parto / Colostrum production and litter performance of sows multiparous submitted to farrowing inductionOtto, Mateus Anderson January 2014 (has links)
A baixa ingestão de colostro compromete a sobrevivência e o desempenho dos leitões. O objetivo do estudo foi avaliar a produção de colostro de matrizes submetidas à indução ao parto aos 114 dias de idade gestacional e sua influência na taxa de sobrevivência na maternidade e desempenho dos leitões. A produção de colostro foi estimada em 96 matrizes de ordem de parto 3 a 7, divididas em dois grupos: Controle (n=48) composto por fêmeas com parto espontâneo e Induzido (n=48) composto por fêmeas induzidas ao parto aos 114 dias de gestação com análogo da PGF2α. Todos os leitões foram pesados ao nascer e 24 horas depois para estimar a produção de colostro através do ganho de peso individual. Amostras de sangue foram coletadas dos leitões no primeiro dia após o nascimento. Foram coletadas amostras de colostro e sangue de cada fêmea no momento do parto e 24 horas depois. Para avaliar o desempenho dos leitões durante a lactação foram acompanhadas 28 leitegadas de cada grupo contendo 12 leitões cada durante 20 dias após o nascimento. Durante o período lactacional todas as leitegadas foram pesadas nos dia 07, 14 e 20 após o nascimento. A duração da gestação do grupo Controle foi em torno de 12 horas mais longa do que no grupo Induzido (P=0,06). A indução ao parto não afetou (P>0,10) a duração do parto, o número total de leitões nascidos, o número de leitões nascidos vivos, o percentual de natimortos, o peso médio dos leitões, o peso médio da leitegada ao nascimento e a produção de colostro em relação ao grupo controle. Não houve diferença entre os grupos (P>0,05) no percentual de fêmeas com intervenção obstétrica. As concentrações de IgG no soro das fêmeas, dos leitões e do colostro foram similares (P>0,10) entre os dois grupos. Para acompanhar o desempenho dos leitões durante a lactação foram uniformizadas leitegadas com peso inicial e consumo de colostro semelhante (P>0,10) em fêmeas adotivas com semelhante produção de colostro (P>0,10). Não foram observadas diferenças (P>0,10) no peso médio dos leitões e das leitegadas nos dias 07, 14 e 20, bem como não houve diferença (P>0,10) na sobrevivência dos animais no mesmo período. A indução ao parto aos 114 dias de gestação não prejudica a produção de colostro e não altera a quantidade de imunoglobulinas G tanto no colostro quanto no soro dos leitões. O desempenho na fase de lactação de leitegadas de fêmeas induzidas ao parto foi semelhante ao de leitegadas de fêmeas com parto espontâneo. / Low colostrum intake influences piglet survival and performance. The aim of this study was to evaluate colostrum production by sows submitted to farrowing induction and its influence on pre-weaning survival rate and piglet performance. A total of 96 sows of parities three to seven were assigned into two groups: Control (n = 48) composed of sows with spontaneous labor and Induced (n = 48) composed of sows induced on day 114 with PGF2α analogue. Colostrum production was estimated by piglet individual weight gain in the first day of life, which was measured by weighing piglets at birth and 24 hours later. Blood samples were collected from piglets on the first day after birth. Colostrum and blood samples were collected from each sow at farrowing and 24 hours later. To evaluate piglet performance during lactation 28 litters from each group containing 12 piglets each were followed for 20 days after birth. During lactation period, all piglets were weighed on days 07, 14 and 20 after birth. Gestation length of control group was about 12 hours longer than induced group (P = 0.06). Farrowing duration, total born, born alive, stillborn rate, average piglet weight, average litter weight at birth and colostrum production were not significantly affected (P > 0.10) by induction of farrowing compared to control group. There was no difference (P > 0.05) in the percentage of sows with obstetric intervention between groups. IgG concentration in sow and piglet serum and colostrum were similar (P > 0.10) between groups. To monitor piglet performance during lactation litters with similar initial weight and colostrum intake (P > 0.10) were cross-fostered in sows with similar colostrum production (P > 0.10). No differences (P > 0.10) were observed in the average piglet and litter weight on days 07, 14 and 20, and on survival rate in the same period. Induction of labor at 114 days of gestation doesn’t affect colostrum production nor influence colostrum and piglet serum immunoglobulin G level. Litter performance during lactation was similar in sows with induced parturition and spontaneous labor.
|
247 |
ROTAS DE SINALIZAÇÃO NA DIVERGÊNCIA FOLICULAR E LUTEÓLISE EM BOVINOS / SIGNALING PATHWAYS DURING FOLLICULAR DEVIATION AND LUTEOLYSIS IN CATTLERovani, Monique Tomazele 12 September 2014 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / It is well established that locally produced factors exert pivotal roles during dominant follicle selection, oocyte maturation, ovulation and luteolysis. However, the identification of these factors and pathways involved in these processes are not yet established. In the present study, we focused on the in vivo bovine models to study reproductive physiology, which were used to identify receptors and intracellular signaling pathways involved in follicle selection and luteolysis. In the first study, it was reviewed the in vivo models used in our lab, describing and discussing the different bovine models and techniques currently used to study ovarian physiology in this mono-ovulatory specie. In a second study, it was evaluated the expression of estrogen receptors (ESRs) before (day 2 of follicular wave), during (day 3) and after (day 4) follicular deviation in cattle. ESR1 and ESR2 transcripts levels were higher in dominant (F1) than subordinate (F2) follicle after follicular deviation. FSH treatment maintained mRNA levels of both ESR1 and ESR2 in F2 follicles at similar levels observed in F1 follicles. Intrafollicular injection of 100 μM fulvestrant (an antagonist of ESRs) inhibited follicular growth and decreased CYP19A1 mRNA levels. Transcript levels of both ESR1 and ESR2 were not affected by fulvestrant injection. In the third study, our objective was to demonstrate the role of the transcription factor signal transducer and activator of transcription 3 (STAT3) and the nuclear receptor 5A2 (NR5A2) in luteolysis. Luteal and blood samples were collected from separate groups of cows on Day 10 of the estrous cycle 0, 2, 12, 24, and 48 hours after prostaglandin F2 alpha (PGF) treatment. Serum progesterone concentrations decreased (P < 0.05) within 2h and the histological examination of the corpus luteum at 24 and 48h after PGF treatment confirmed functional and morphological luteolysis, respectively. The abundance of STAR mRNA and protein decreased at 12h after PGF treatment. The abundance of NR5A2 mRNA and protein decreased (P < 0.05) at 12 and 24h post-PGF, respectively. Levels of STAT3 mRNA remained constant (P > 0.05) throughout the time-points evaluated. However, the abundance of phosphorylated isoform of STAT3, normalized to total STAT3, increased reaching a peak at 12h and remaining high until 48h after PGF treatment. In conclusion, bovine in vivo models provide a valuable system to study reproductive events under physiological endocrine environment while keeping intact the communication between follicular cells through autocrine and paracrine signaling, without the need to perform ovariectomy or euthanaze the animals. Our results suggest that both ESR1 and ESR2 are regulated during follicular deviation and dominance and in response to FSH treatment in cattle, ESRs are required for normal gene expression and development of the dominant follicle. PGF treatment results in decreased expression of the nuclear receptor NR5A2 and activation of STAT3 by phosphorylation in bovine luteal cells. / É bem estabelecido que fatores produzidos localmente exercem papel essencial durante a seleção do folículo dominante, maturação oocitária, ovulação e luteólise. No entanto, os fatores e vias envolvidas nestes processos não estão totalmente estabelecidos. No presente estudo, enfatizou-se o uso de modelos bovinos in vivo para o estudo da fisiologia reprodutiva, sendo aqui utilizados para identificar receptores e vias de sinalização intracelular envolvidas na seleção do folículo e luteólise. No primeiro estudo, revisaram-se os modelos in vivo utilizados em nosso laboratório, descreveram-se e discutiram-se os diferentes modelos em bovinos e técnicas atualmente utilizadas para estudar fisiologia ovariana nesta espécie monovulatória. Em um segundo estudo, avaliou-se a expressão de receptores de estradiol (ESRS) antes (dia 2 da onda folicular), durante (dia 3) e após (dia 4) a divergência folicular em bovinos. Os níveis dos transcritos ESR1 e ESR2 foram maiores no folículo dominante (F1) que no subordinado (F2) após a divergência folicular. O tratamento com FSH manteve os níveis de RNAm de ambos ESR1 e ESR2 nos folículos F2 em níveis semelhantes aos observados em folículos F1. A injeção intrafolicular de 100 uM de fulvestrant (um antagonista de ESRs) inibiu o crescimento folicular e causou uma diminuição dos níveis de RNAm de CYP19A1. Os níveis de transcritos, tanto para ESR1 e ESR2, não foram afetados pela injeção de fulvestrant. Num terceiro estudo, o nosso objetivo foi demonstrar o papel do Transdutor de sinais e ativador de transcrição 3 (STAT3) e do receptor nuclear 5A2 (NR5A2) na luteólise. Amostras de corpo lúteo (CL) e sangue foram coletadas dos grupos de vacas 0, 2, 12, 24 e 48 horas após o tratamento com prostaglandina F2 alpha (PGF) no dia 10 do ciclo estral. A concentração de progesterona sérica diminuiu (P < 0.05) em 2 horas e o exame histológico do CL às 24h e 48h após o tratamento com PGF confirmou a ocorrência de luteólise funcional e morfológica, respectivamente. A abundância de RNAm e proteína de STAR diminuiu às 12h após o tratamento com PGF. A abundância de RNAm e proteína de NR5A2 diminuiu (P < 0.05) às 12 e 24 horas pós-PGF, respectivamente. Os níveis de RNAm de STAT3 permaneceram constantes (P> 0.05) ao longo do tempo avaliado. No entanto, a abundância da isoforma fosforilada de STAT3, normalizados para STAT3 total, aumentou, atingindo um pico às 12h e permaneceu elevada até 48h após o tratamento com PGF. Em conclusão, os modelos bovinos in vivo fornecem um sistema valioso para estudar os eventos reprodutivos sob ambiente fisiológico, mantendo intacta a comunicação entre as células foliculares através de sinalização autócrina e parácrina, reduzindo a necessidade de realizar ovariectomia ou realizar a eutanásia dos animais. Nossos resultados sugerem que tanto ESR1 como ESR2 são regulados durante a divergência e dominância folicular em bovinos e em resposta ao tratamento com FSH, e ESRs são necessários para a expressão gênica e para o desenvolvimento do folículo dominante. O tratamento com PGF resulta em diminuição da expressão do receptor nuclear NR5A2 e ativação de STAT3 por fosforilação em células luteais bovinas.
|
248 |
ROTA DE AÇÃO DA PROSTAGLANDINA F22 α ADMINISTRADA VIA SUBMUCOSA VULVAR NA LUTEÓLISE DE BOVINOS / ROUTE OF ACTION OF PROSTAGLANDIN F2α AFTER INTRAVULVOSUBMUCOUS INJECTION IN BOVINE LUTEOLYSISRovani, Monique Tomazele 16 September 2011 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The aim of this study was to verify if prostaglandin F2α (PGF2α) administered by
intravulvosubmucous (IVSM) injection induces luteolysis by reaching the corpus luteum (CL)
directly by a local absorption rote, preventing its metabolism in the lungs, or after absorption
and distribution via the systemic circulation. In a first trial, the estrus rate of 1,937 beef cows
was monitored for 5 days (25.6% of estrus). At day 5, the cows that did not show estrus
received 1/5 of the standard dose of dinoprost IVSM (5 mg; n = 1440) and resulted in 68.2%
of estrus in the next 5 days. However, in a second trial, the number of heifers detected in
estrus after dinoprost injected via the IVSM (47.4%; n = 97) or intramuscular route (IM;
54.7%; n = 95) at day 5 was not different (P > 0.05). Based on serum progesterone
concentrations, animals treated with 5 mg dinoprost at day 5 of the estrous cycle do not
present functional luteolysis regardless of the administration route. At day 10 of the estrous
cycle, luteolysis was variable in cows treated with 5 mg of dinoprost. Nevertheless, luteolysis
occurred in all animals treated with 25 mg dinoprost independent of the estrous cycle day.
After treatment, the PGF2α concentration did not differ in serum from uterine and jugular
veins. This was further confirmed by measuring the concentration of 13,14-dihydro-15-keto-
PGF (PGFM) after 5 mg dinoprost injection via the IM or IVSM route. Dinoprost IM- and
IVSM-administered resulted in a similar PGFM serum pattern over time, suggesting the same
absorption rate for both routes. Although anatomical evidences suggest that PGF2α injected
IVSM could be taken direct to the ovaries, avoiding the systemic circulation, the results do
not support this hypothesis. In summary, the route of PGF2α administration (IVSM or IM)
resulted in similar serum concentrations of PGF2α, PGFM, and luteolysis. Taking all the
results together, the PGF2α injection via IVSM reached the systemic circulation before
reaching the ovary, and the effectiveness of low doses of PGF2α was dependent on luteal
phase and not on the route of administration. / O presente trabalho teve por objetivo verificar se a prostaglandina F2α (PGF2α)
administrada na submucosa vulvar (IVSM) induz a luteólise ao alcançar o corpo lúteo (CL)
diretamente por uma via local, evitando sua metabolização nos pulmões, ou após a absorção e
distribuição através da circulação sistêmica. Em um primeiro estudo, o estro de 1937 vacas de
corte foi monitorado durante 5 dias (25,6% de estro). No dia 5, as vacas que não apresentaram
estro receberam 5mg de dinoprost via IVSM (1/5 da dose padrão; n=1440), resultando em
68,2% de estro nos 5 dias seguintes. Todavia, em outro experimento utilizando a mesma dose,
o número de novilhas detectadas em estro após o tratamento IVSM (47,4%, n=97) ou
intramuscular (IM; 54,7%, n=95) no dia 5 não diferiu entre os grupos (P>0,05). Com base na
concentração sérica de progesterona, os animais tratados com 5mg de dinoprost no dia 5 do
ciclo estral não apresentaram luteólise funcional, independentemente da via de administração.
Após o tratamento com 5mg dinoprost IM ou IVSM no dia 10 do ciclo, 3/5 e 2/5 animais
apresentaram luteólise, respectivamente. Entretanto, a luteólise ocorreu em todos os animais
tratados com 25mg de dinoprost, independente do dia do ciclo estral (dia 5 ou 10). A
concentração de PGF2α não diferiu no soro das veias uterina e jugular. O mesmo foi
observado quanto ao padrão de 13,14-dihidro-15-ceto prostaglandina F2α (metabólito de
PGF2α; PGFM) sérico ao longo do tempo após a aplicação de 5 mg de dinoprost via IM ou
IVSM. Em resumo, a via de administração de PGF2α (IVSM ou IM) resultou em
concentrações séricas semelhante de PGF2α, PGFM e luteólise. Embora evidências anatômicas
permitam sugerir que a PGF2α injetada via IVSM possa ser transportada diretamente aos
ovários, a injeção de PGF2α via IVSM atinge a circulação sistêmica antes de chegar ao ovário,
e a eficácia de baixas doses de PGF2α é dependente da fase luteal e não da via de administração.
|
249 |
O Uso terapêutico de mediadores anti-inflamatórios da via do ácido araquidônicoSilva, Carlos Antonio Trindade da 29 June 2016 (has links)
O ácido araquidônico (AA) é precursor na formação dos eicosanoides, que são mediadores lipídicos com uma série de funções na fisiologia e patologia humana. A maioria dos eicosanoides atuam como mediadores pró-inflamatórios e contribuem para o desenvolvimento e proliferação de tumores. Nesta tese foram avaliados dois mediadores: a 15-deoxi-Δ12,14-PGJ2 (15d- PGJ2) e os ácidos Epoxieicosatrienoicos (EETs), ambos apresentam uma atividade oposta a da maioria dos eicosanoides, ou seja, com uma ação anti-inflamatória e antitumoral. Esses dois mediadores distintos da via do AA foram utilizados nesta tese em dois projetos distintos. Primeiro: A 15d- PGJ2 possui uma atividade antiproliferativa e induziu apoptose para diversos tipos de células tumorais, entretanto, o efeito da15d- PGJ2 em células de cancer da tireoide ainda estava desconhecido. Neste sentido, foram cultivadas in vitro células tumorais da tireoide, da linhagem TPC1, e tratadas com diferentes concentrações de 15d- PGJ2 (0 ate 20 μM), as células tratadas demonstraram uma diminuição na proliferação, e aumento na apoptose, e uma diminuição na liberação e expressão relativa de IL-6. Estes resultados em conjunto sugerem que a 15d- PGJ2 pode ser utilizada como uma nova terapia para o cancer da tireoide. Segundo: Os EETs são metabolizados em seus diois pela epóxi hidrolase solúvel (sEH), para manter a estabilidade dos EETs e a sua atividade antiiflamatoria, foi utilizado um inibidor (TPPU) para sEH em um modelo de periodontite induzida por Aggregatibacter actinomycetemcomitans. O tratamento oral com TPPU, assim como o uso de animais sEH Knockout, levou a uma redução na perda óssea acompanhada da diminuição de moléculas osteoclastogenicas como RANK, RANKL e OPG, demonstrando que a inibição farmacológica da sEH pode ter um valor terapêutico na periodontite e doenças inflamatórias que envolvem a reabsorção óssea. / Arachidonic acid (AA) a precursor in the formation of eicosanoids which are lipid mediators with a number of functions in human physiology and pathology. The most of the eicosanoids act as proinflammatory mediators and contribute to the development and proliferation of tumors. In this thesis we evaluated two mediators: 15-deoxy-Δ12,14-PGJ2 (15d- PGJ2) and epoxieicosatrienoic acids (EETs) both act with an opposite activity of most eicosanoids, with an anti-inflammatory and and anti-tumoral action these two distinct mediators from AA pathway were used in this thesis in two different projects. First: 15d- PGJ2, was described that to have an antiproliferative activity and to induce apoptosis in several types of tumor cells however, the effect of 15d- PGJ2 in thyroid cancer cells was unknown in this sense, we tested in vitro cultured thyroid tumor cells, here in TPC1 cells, and treated with different concentrations of 15d- PGJ2 (0 to 20 uM) the treated cells showed a decrease in proliferation and an increase in apoptosis and a decrease in IL-6 release and relative expression. These key results together demonstrate that 15d- PGJ2 can be used as a new therapy for thyroid cancer. Second: The EETs are converted to their diols by soluble epoxy hydrolase (sEH) to maintain the stability of EETs and their anti-inflammatory activity, an inhibitor (TPPU) against was used to sEH in a periodontitis model induced with Aggregatibacter actinomycetemcomitans. The oral treatment in mice with TPPU and sEH Knockout animals showed bone loss reduction accompanied by a decrease in the osteoclastogenic molecules, like RANK, RANKL and OPG, demonstrating that pharmacological inhibition of sEH may have therapeutic value in periodontitis and inflammatory diseases that involve bone resorption. / Tese (Doutorado)
|
250 |
Produção de colostro e desempenho da leitegada em fêmeas suínas multíparas submetidas à indução em parto / Colostrum production and litter performance of sows multiparous submitted to farrowing inductionOtto, Mateus Anderson January 2014 (has links)
A baixa ingestão de colostro compromete a sobrevivência e o desempenho dos leitões. O objetivo do estudo foi avaliar a produção de colostro de matrizes submetidas à indução ao parto aos 114 dias de idade gestacional e sua influência na taxa de sobrevivência na maternidade e desempenho dos leitões. A produção de colostro foi estimada em 96 matrizes de ordem de parto 3 a 7, divididas em dois grupos: Controle (n=48) composto por fêmeas com parto espontâneo e Induzido (n=48) composto por fêmeas induzidas ao parto aos 114 dias de gestação com análogo da PGF2α. Todos os leitões foram pesados ao nascer e 24 horas depois para estimar a produção de colostro através do ganho de peso individual. Amostras de sangue foram coletadas dos leitões no primeiro dia após o nascimento. Foram coletadas amostras de colostro e sangue de cada fêmea no momento do parto e 24 horas depois. Para avaliar o desempenho dos leitões durante a lactação foram acompanhadas 28 leitegadas de cada grupo contendo 12 leitões cada durante 20 dias após o nascimento. Durante o período lactacional todas as leitegadas foram pesadas nos dia 07, 14 e 20 após o nascimento. A duração da gestação do grupo Controle foi em torno de 12 horas mais longa do que no grupo Induzido (P=0,06). A indução ao parto não afetou (P>0,10) a duração do parto, o número total de leitões nascidos, o número de leitões nascidos vivos, o percentual de natimortos, o peso médio dos leitões, o peso médio da leitegada ao nascimento e a produção de colostro em relação ao grupo controle. Não houve diferença entre os grupos (P>0,05) no percentual de fêmeas com intervenção obstétrica. As concentrações de IgG no soro das fêmeas, dos leitões e do colostro foram similares (P>0,10) entre os dois grupos. Para acompanhar o desempenho dos leitões durante a lactação foram uniformizadas leitegadas com peso inicial e consumo de colostro semelhante (P>0,10) em fêmeas adotivas com semelhante produção de colostro (P>0,10). Não foram observadas diferenças (P>0,10) no peso médio dos leitões e das leitegadas nos dias 07, 14 e 20, bem como não houve diferença (P>0,10) na sobrevivência dos animais no mesmo período. A indução ao parto aos 114 dias de gestação não prejudica a produção de colostro e não altera a quantidade de imunoglobulinas G tanto no colostro quanto no soro dos leitões. O desempenho na fase de lactação de leitegadas de fêmeas induzidas ao parto foi semelhante ao de leitegadas de fêmeas com parto espontâneo. / Low colostrum intake influences piglet survival and performance. The aim of this study was to evaluate colostrum production by sows submitted to farrowing induction and its influence on pre-weaning survival rate and piglet performance. A total of 96 sows of parities three to seven were assigned into two groups: Control (n = 48) composed of sows with spontaneous labor and Induced (n = 48) composed of sows induced on day 114 with PGF2α analogue. Colostrum production was estimated by piglet individual weight gain in the first day of life, which was measured by weighing piglets at birth and 24 hours later. Blood samples were collected from piglets on the first day after birth. Colostrum and blood samples were collected from each sow at farrowing and 24 hours later. To evaluate piglet performance during lactation 28 litters from each group containing 12 piglets each were followed for 20 days after birth. During lactation period, all piglets were weighed on days 07, 14 and 20 after birth. Gestation length of control group was about 12 hours longer than induced group (P = 0.06). Farrowing duration, total born, born alive, stillborn rate, average piglet weight, average litter weight at birth and colostrum production were not significantly affected (P > 0.10) by induction of farrowing compared to control group. There was no difference (P > 0.05) in the percentage of sows with obstetric intervention between groups. IgG concentration in sow and piglet serum and colostrum were similar (P > 0.10) between groups. To monitor piglet performance during lactation litters with similar initial weight and colostrum intake (P > 0.10) were cross-fostered in sows with similar colostrum production (P > 0.10). No differences (P > 0.10) were observed in the average piglet and litter weight on days 07, 14 and 20, and on survival rate in the same period. Induction of labor at 114 days of gestation doesn’t affect colostrum production nor influence colostrum and piglet serum immunoglobulin G level. Litter performance during lactation was similar in sows with induced parturition and spontaneous labor.
|
Page generated in 0.0798 seconds